A cochlear implant is an electronic medical device that transmits
sound signals to the brain. With the cochlear implant, a person can
achieve better sentence understanding as compared to hearing aids. At
present, cochlear implants are the only effective means allowing the
social interaction of individuals suffering from hearing loss. The
first cochlear implant was approved by the FDA in 1984, which made 3M
an industrial leader.
Increasing incidence of neonates born with hearing defects is driving
the market cochlear implant systems. According to WHO hearing loss
statistics, each year, approximately, 134 million children are born,
out of which approximately 1 to 3 newborns per 1,000 are with hearing
loss, which is treatable only with a cochlear implant. Thus, there is
a need for a minimum of 134,000 cochlear implants annually. The
number of cochlear implants is likely to increase to approximately
160,000 per year if the hearing loss is considered for both ears.
Apart from the rising number of patients suffering from hearing loss,
technological advancements, strategic initiatives by industry
players, and favorable government regulations are driving the growth
of the global cochlear implant systems market in 2016.
For instance, in1979, the University of Melbourne and Nucleus Limited
got approval from the Australian Department of Productivity to
manufacture and market 22 cochlear implants. In another event, the
National Institutes of Health (NIH) funded the first consensus
conference to speed up the acceptance of multi-electrode cochlear
implants. Market players are focused on the development of devices
with reduced noise, quickly chargeable, long battery life, and
waterproof. According to the World Health Organization (WHO), the
current production of hearing loss aids is only 10% of the actual
need; thus, there is a lucrative opportunity for new players to enter
the global cochlear implant systems market.
The global cochlear implant systems market has been segmented based
on type of fitting, end-user, and region. Based on type of fitting,
the market is segmented into unilateral implantation and bilateral
implantation. The unilateral implantation segment dominates the
global cochlear implant systems market owing to low cost. Unilateral
implantation is common in adults. The bilateral implantation segment
is expected to expand at a fast growth rate during the forecast
period owing to rising demand for cochlear implants by pediatric
patients suffering from hearing loss. Moreover, several countries are
offering reimbursement only for bilateral implantation contributing
to the growth of the segment. In terms of end-user, the market is
segmented into hospitals, ENT clinics, and other end-users.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34124
The ENT clinics segment dominate the global cochlear implant systems
market in 2016, owing to increasing patient population suffering from
hearing loss, and growing patient preference towards treatment in ENT
clinics in emerging countries. According to WHO estimates in 2012,
out of the total worldwide population with hearing impairment, 91%
were adults and 9% were children.
Geographically, the global cochlear implant systems market is
distributed over North America, Europe, Latin America, Asia Pacific,
and Middle East & Africa. Asia Pacific region is expected to
dominate the global cochlear implant systems market owing to the high
prevalence of hearing defects in the region. Middle East & Africa
region is expected to account for the second largest share in 2016.
This is attributable to the highest incidence of otitis media, ear
infections owing to lack of proper hygiene practices, and increasing
pregnancy and genetic complications leading to hearing loss in
neonates. Europe is the next largest market for cochlear implants
owing to increasing geriatric population.
Key players operating in the global cochlear implant systems market
include MED-EL, Cochlear Limited, Oticon Medical, William Demant
Holding A/S, LSVT Global, Inc., PENTAX Medical, EBS Healthcare,
Sonova, Gaes Medica, and Nurotron Biotechnology Co., Ltd.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=34124<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment